Rectally-Applied Dapivirine Safety and PK Study
Protocol Title
A Double Blind Randomized Phase 2A Study of Dapivirine 0.05% gel Applied Rectally in HIV-1 Seronegative Adults
DAIDS Protocol ID
30010
Status
Withdrawn